• Patients over the age of 17 years should be referred to the Barnes-Jewish Hospital Lung Transplant Program.
  • Children from birth to 17 years of age, with end stage pulmonary parenchymal or pulmonary vascular disease and:
    • Likelihood of recurrence of the disease after transplant is small.
    • No evidence of irreversible organ dysfunction likely to progress or complicate the transplant.
    • No contraindication to immunosuppression.
    • Family and patient committed to adherence to complicated medical regimens.
  • Child is psychologically stable with a stable family structure.